In addition, MC3181 displayed a greater selectivity toward GSTP1-1, high cytotoxicity toward osteosarcoma cells, as well as a panel of different human melanoma cell lines, and exhibited a remarkable therapeutic activity against BRAF-V600E-mutant xenografts [12,20,69]. This evidence concerns the gene GSTP1 and osteosarcoma.